FLGT – fulgent genetics, inc. (US:NASDAQ)
Stock Stats
News
Oncology Specimen Provider Reference Medicine Announces Launch of Characterized Specimens, Enabling Increased Speed and Efficiency for Assay Developers
Fulgent Genetics, Inc. (NASDAQ: FLGT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Fulgent Genetics, Inc. (NASDAQ: FLGT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Fulgent Genetics, Inc. (NASDAQ: FLGT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Fulgent Genetics, Inc. (NASDAQ: FLGT) had its price target lowered by analysts at Piper Sandler from $26.00 to $22.00. They now have a "neutral" rating on the stock.
Form 10-Q Fulgent Genetics, Inc. For: Sep 30
Form 8-K Fulgent Genetics, Inc. For: Nov 08
Form SC 13D/A Fulgent Genetics, Inc. Filed by: Hsieh Ming
Form 4 Fulgent Genetics, Inc. For: Nov 01 Filed by: Hsieh Ming
Form 4 Fulgent Genetics, Inc. For: Oct 30 Filed by: Gao Hanlin
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.